Is Applied Therapeutics, Inc. (APLT) a Buy, Sell, or Hold?
Applied Therapeutics, Inc.
NASDAQ:APLT
$0.103 USD
$0.0 (0.0%)
- Volume
- 0
- Average Volume
- 15.8M
- Market Capitalization
- $14.86M
- P/E Ratio
- -0.24
- Dividend Yield
- 0.00%
- Price Target
- $2.13
- Year High
- $1.50
- Year Low
- $0.09
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.96
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Les D. Funtleyder |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | APLT |
| CUSIP | 03828A101 |
| CIK | 0001697532 |
| Web | https://www.appliedtherapeutics.com |
| Phone | 212 220 9226 |
| Currency | USD |
| Employees | 35 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | -4.46 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.96 |
| Quick Ratio | 0.96 |
| Cash Ratio | 0.36 |
Sales & Book Value
| Annual Sales | $455K |
| Price / Sales | 14.86 |
| Cash Flow | -0.46 |
| Price / Cash Flow | -0.22 |
| Price / Book | -26.72 |
Price Target and Rating
| Average Stock Price Forecast | $2.13 |
| High Stock Price Forecast | $4.00 |
| Low Stock Price Forecast | $0.25 |
| Forecast Upside/Downside | -95.15% |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 11 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.76 |
| Trailing P/E Ratio | -0.24 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-105.62M |
| Net Margin | -6214.50% |
| Pretax Margin | -6214.50% |
| Return on Equity | -348.18% |
| Return on Assets | -180.79% |
Financials Score
| AltmanZ Score | -27.42 |
| Piotroski Score | 1.00 |
| Working Capital | -1.25M |
| Total Assets | 34.37M |
| Ebit | -18.14M |
| Market Cap | 14.86M |
| Total Liabilities | 34.94M |
Poll Results
About Applied Therapeutics, Inc. (NASDAQ:APLT) Stock
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for cardiovascular conditions, galactosemia, and various diabetes-related complications. The company's primary drug candidate, AT-007, has successfully concluded Phase 1/2 studies for galactosemia in healthy adult volunteers and is presently in a pediatric clinical study for the same indication in children. Additionally, AT-007 is being investigated for its potential to address sorbitol dehydrogenase deficiency and phosphomannomutase enzyme-CDG. Another key compound, AT-001, is currently undergoing pivotal Phase III clinical trials. This therapy is being evaluated for its efficacy in treating both diabetic cardiomyopathy and diabetic peripheral neuropathy. Beyond its clinical ... pipeline, the company also maintains an early-stage preclinical portfolio. This includes AT-003, which is being developed for diabetic retinopathy, and AT-104. AT-104 is a PI3K inhibitor specifically designed to target T-Cell Acute Lymphoblastic Leukemia, a rare form of blood cancer. Applied Therapeutics, Inc. was established in 2016 and operates from its headquarters in New York City.
Frequently Asked Questions
-
What is the current Applied Therapeutics, Inc. (APLT) stock price?
-
Applied Therapeutics, Inc.(NASDAQ:APLT) stock price is $0.103 in the last trading session. During the trading session, APLT stock reached the peak price of $1.5 while $0.09 was the lowest point it dropped to. The percentage change in APLT stock occurred in the recent session was 0.0% while the dollar amount for the price change in APLT stock was $0.0.
-
APLT's industry and sector of operation?
-
The NASDAQ listed APLT is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of APLT?
-
Todd F. Baumgartner | Chief Regulatory Officer
Corwin Dale Hooks | Chief Commercial Officer
Catherine Thorpe | Interim Chief Accounting Officer
Dottie Caplan | Executive Vice President of Patient Advocacy & Government Affairs.
Reena Thomas Colacot | Head of Quality -
How many employees does APLT have?
-
Number of APLT employees currently stands at 35. APLT operates from 545 Fifth Avenue, New York City, NY 10017, US.
-
Link for APLT official website?
-
Official Website of APLT is: https://www.appliedtherapeutics.com
-
How do I contact APLT?
-
APLT could be contacted at phone #212 220 9226 and can also be accessed through its website. APLT operates from 545 Fifth Avenue, New York City, NY 10017, US.
-
How many shares of APLT are traded daily?
-
The average number of APLT shares traded daily for last 3 months was 15.8M.
-
What is the market cap of APLT currently?
-
The market value of APLT currently stands at $14.86M with its latest stock price at $0.103